miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options.
Saadi MI, Nikandish M, Ghahramani Z, Valandani FM, Ahmadyan M, Hosseini F, Rahimian Z, Jalali H, Tavasolian F, Abdolyousefi EN, Kheradmand N, Ramzi M.
Saadi MI, et al. Among authors: ghahramani z.
J Egypt Natl Canc Inst. 2023 Jun 19;35(1):18. doi: 10.1186/s43046-023-00174-3.
J Egypt Natl Canc Inst. 2023.
PMID: 37332027